Analyst Consensus ?
ConsensusBuy29 ratings
Bullish2275.9%
Neutral724.1%
Bearish00.0%
FN2 Earnings Intelligence
GE Vernova Inc. (GEV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Susquehanna | Positive | Positive | Maintain | Oct 14, 2026 |
| Guggenheim | Buy | Buy | Maintain | Oct 13, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 9, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 15, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 27, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 11, 2026 |
| BNP Paribas | Neutral | Outperform | Downgrade | Apr 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 23, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 31, 2026 |
| Rothschild & Co | Buy | Sell | Upgrade | Mar 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 29, 2026 |
| GLJ Research | Buy | Buy | Maintain | Jan 12, 2026 |
| Seaport Global | Neutral | Buy | Downgrade | Dec 11, 2025 |
| UBS | Buy | Buy | Maintain | Dec 10, 2025 |
| B of A Securities | Buy | Buy | Maintain | Dec 10, 2025 |
| Melius Research | Buy | Hold | Upgrade | Sep 15, 2025 |
| HSBC | Hold | Hold | Maintain | Sep 5, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 13, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jan 23, 2025 |
| Daiwa Capital | Buy | Outperform | Maintain | Oct 30, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 2, 2024 |
Upside is calculated against the persisted current price $855.12. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Susquehanna | Analyst unavailable | $1,270 | $1,004.04 | +48.5% | Oct 14, 2026 |
| Evercore ISI | Alex Virgo | $1,350 | $950.49 | +57.9% | Oct 1, 2026 |
| Jefferies | Analyst unavailable | $1,185 | $953.2 | +38.6% | Sep 11, 2026 |
| Mizuho Securities | Maheep Mandloi | $949 | $1,020.52 | +11.0% | Jul 24, 2026 |
| RBC Capital | Analyst unavailable | $1,225 | $1,002.04 | +43.3% | Jul 23, 2026 |
| Oppenheimer | Analyst unavailable | $1,338 | $1,020.58 | +56.5% | Jul 23, 2026 |
| Guggenheim | Joseph Osha | $1,450 | $985.03 | +69.6% | Jul 23, 2026 |
| Bernstein | Sunaina Ocalan | $1,298 | $985.03 | +51.8% | Jul 23, 2026 |
| Bernstein | Sunaina Ocalan | $1,206 | $982.35 | +41.0% | Jun 16, 2026 |
| Bernstein | Sunaina Ocalan | $1,208 | $982.35 | +41.3% | Jun 16, 2026 |
| Jefferies | Julian Dumoulin-Smith | $1,210 | $901.02 | +41.5% | Jun 11, 2026 |
| Argus Research | John Eade | $1,300 | $1,107 | +52.0% | Apr 27, 2026 |
| BNP Paribas | Analyst unavailable | $1,190 | $1,149.19 | +39.2% | Apr 27, 2026 |
| Goldman Sachs | Analyst unavailable | $1,328 | $1,149.53 | +55.3% | Apr 24, 2026 |
| Jefferies | Julien Dumoulin-Smith | $1,350 | $1,149.53 | +57.9% | Apr 24, 2026 |
| Oppenheimer | Analyst unavailable | $1,303 | $1,150.74 | +52.4% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $1,195 | $1,153.57 | +39.7% | Apr 23, 2026 |
| BMO Capital | Analyst unavailable | $1,250 | $1,127.56 | +46.2% | Apr 23, 2026 |
| Susquehanna | Analyst unavailable | $1,300 | $1,127.56 | +52.0% | Apr 23, 2026 |
| Guggenheim | Joseph Osha | $1,300 | $1,127.56 | +52.0% | Apr 23, 2026 |
| Robert W. Baird | Ben Kallo | $1,400 | $1,127.56 | +63.7% | Apr 23, 2026 |
| Barclays | Julian Mitchell | $1,250 | $1,127.56 | +46.2% | Apr 23, 2026 |
| Oppenheimer | Colin Rusch | $1,139 | $982.74 | +33.2% | Apr 16, 2026 |
| Susquehanna | Charles Minervino | $1,080 | $968.02 | +26.3% | Apr 9, 2026 |
| Redburn Partners | Analyst unavailable | $1,100 | $830.1 | +28.6% | Mar 9, 2026 |
| Robert W. Baird | Ben Kallo | $923 | $780.25 | +7.9% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $714 | $754.97 | -16.5% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $849 | $726.37 | -0.7% | Feb 2, 2026 |
| RBC Capital | Analyst unavailable | $800 | $717.39 | -6.4% | Jan 30, 2026 |
| Guggenheim | Analyst unavailable | $910 | $717.39 | +6.4% | Jan 30, 2026 |
| UBS | Analyst unavailable | $936 | $694.64 | +9.5% | Jan 29, 2026 |
| UBS | Analyst unavailable | $871 | $708.31 | +1.9% | Jan 29, 2026 |
| Evercore ISI | Alexander Virgo | $905 | $707.73 | +5.8% | Jan 29, 2026 |
| Robert W. Baird | Analyst unavailable | $701 | $711.59 | -18.0% | Jan 29, 2026 |
| BMO Capital | Analyst unavailable | $785 | $711.59 | -8.2% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $820 | $711.59 | -4.1% | Jan 29, 2026 |
| Jefferies | Julian Dumoulin-Smith | $930 | $688.5 | +8.8% | Jan 29, 2026 |
| Goldman Sachs | Analyst unavailable | $925 | $711.59 | +8.2% | Jan 29, 2026 |
| Morgan Stanley | David Arcaro | $817 | $657.78 | -4.5% | Jan 26, 2026 |
| GLJ Research | Austin Wang | $1,087 | $622.5 | +27.1% | Jan 12, 2026 |
| Robert W. Baird | Ben Kallo | $649 | $628.4 | -24.1% | Jan 9, 2026 |
| Barclays | Analyst unavailable | $830 | $686.33 | -2.9% | Jan 7, 2026 |
| Jefferies | Julien Dumoulin-Smith | $830 | $658.28 | -2.9% | Dec 22, 2025 |
| Robert W. Baird | Analyst unavailable | $816 | $650.82 | -4.6% | Dec 18, 2025 |
| Jefferies | Analyst unavailable | $815 | $614.19 | -4.7% | Dec 18, 2025 |
| Goldman Sachs | Joe Ritchie | $840 | $681.35 | -1.8% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $822 | $681.35 | -3.9% | Dec 16, 2025 |
| Wells Fargo | Michael Blum | $831 | $681.35 | -2.8% | Dec 16, 2025 |
| Evercore ISI | Alexander Virgo | $860 | $672.56 | +0.6% | Dec 15, 2025 |
| Seaport Global | Tom Curran | $723 | $690.15 | -15.5% | Dec 11, 2025 |
| UBS | Amit Mehrotra | $835 | $713.78 | -2.4% | Dec 10, 2025 |
| Susquehanna | Charles Minervino | $775 | $625.3 | -9.4% | Dec 10, 2025 |
| BMO Capital | Ameet Thakkar | $780 | $625.3 | -8.8% | Dec 10, 2025 |
| RBC Capital | Christopher Dendrinos | $761 | $625.3 | -11.0% | Dec 10, 2025 |
| Oppenheimer | Colin Rusch | $855 | $625.3 | -0.0% | Dec 10, 2025 |
| Barclays | Julian Mitchell | $720 | $601.97 | -15.8% | Dec 4, 2025 |
| Morgan Stanley | Analyst unavailable | $710 | $577.97 | -17.0% | Oct 30, 2025 |
| Jefferies | Julian Dumoulin-Smith | $654 | $585.34 | -23.5% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $660 | $609.65 | -22.8% | Oct 24, 2025 |
| RBC Capital | Christopher Dendrinos | $630 | $586.85 | -26.3% | Oct 23, 2025 |
| BMO Capital | Analyst unavailable | $710 | $576 | -17.0% | Oct 23, 2025 |
| Susquehanna | Analyst unavailable | $750 | $576 | -12.3% | Oct 23, 2025 |
| UBS | Analyst unavailable | $710 | $592.21 | -17.0% | Oct 23, 2025 |
| Morgan Stanley | Analyst unavailable | $690 | $615.95 | -19.3% | Oct 16, 2025 |
| GLJ Research | Analyst unavailable | $758 | $658.98 | -11.4% | Oct 15, 2025 |
| Mizuho Securities | Maheep Mandloi | $677 | $644.41 | -20.8% | Oct 15, 2025 |
| Redburn Partners | Analyst unavailable | $475 | $644.41 | -44.5% | Oct 15, 2025 |
| Susquehanna | Charles Minervino | $740 | $628.36 | -13.5% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $605 | $614.9 | -29.2% | Oct 1, 2025 |
| Melius Research | Analyst unavailable | $740 | $625.55 | -13.5% | Sep 15, 2025 |
| Seaport Global | Tom Curran | $630 | $540.07 | -26.3% | Jul 10, 2025 |
| UBS | Amit Mehrotra | $614 | $517.04 | -28.2% | Jul 7, 2025 |
| Susquehanna | Charles Minervino | $370 | $330.8 | -56.7% | Apr 2, 2025 |
| Truist Financial | Analyst unavailable | $440 | $303 | -48.5% | Mar 27, 2025 |
| RBC Capital | Analyst unavailable | $445 | $317.06 | -48.0% | Mar 18, 2025 |
| New Street | Analyst unavailable | $380 | $316.8 | -55.6% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $380 | $316.8 | -55.6% | Mar 5, 2025 |
| BMO Capital | Analyst unavailable | $420 | $315.98 | -50.9% | Mar 3, 2025 |
| Guggenheim | Joseph Osha | $400 | $351.46 | -53.2% | Dec 5, 2024 |
| Mizuho Securities | Maheep Mandloi | $351 | $343.57 | -59.0% | Dec 2, 2024 |
| J.P. Morgan | Mark Strouse | $330 | $295.9 | -61.4% | Oct 24, 2024 |
| RBC Capital | Christopher Dendrinos | $285 | $279.88 | -66.7% | Oct 24, 2024 |
| Goldman Sachs | Joe Ritchie | $324 | $279.88 | -62.1% | Oct 24, 2024 |
| Jefferies | Andrew Tsai | $165 | $274.85 | -80.7% | Oct 21, 2024 |
| Deutsche Bank | Nicole DeBlase | $354 | $272.72 | -58.6% | Oct 21, 2024 |
| RBC Capital | Christopher Dendrinos | $262 | $272 | -69.4% | Oct 18, 2024 |
| Jefferies | Julian Dumoulin-Smith | $336 | $272 | -60.7% | Oct 17, 2024 |
| HSBC | Sean McLoughlin | $255 | $261.61 | -70.2% | Oct 4, 2024 |
| Truist Financial | Jordan Levy | $300 | $255.05 | -64.9% | Sep 26, 2024 |
| Jefferies | Julien Dumoulin-Smith | $293 | $247.39 | -65.7% | Sep 20, 2024 |
| Bank of America Securities | Andrew Obin | $300 | $229.93 | -64.9% | Sep 17, 2024 |
| Mizuho Securities | Maheep Mandloi | $241 | $225.59 | -71.8% | Sep 16, 2024 |
| Barclays | Julian Mitchell | $250 | $225.59 | -70.8% | Sep 16, 2024 |
| Morgan Stanley | Andrew Percoco | $256 | $215.27 | -70.1% | Sep 13, 2024 |
| BMO Capital | Ameet Thakkar | $245 | $215.27 | -71.3% | Sep 13, 2024 |
| Goldman Sachs | Joe Ritchie | $220 | $214.58 | -74.3% | Sep 12, 2024 |
| Jefferies | Julien Dumoulin-Smith | $261 | $192.55 | -69.5% | Sep 3, 2024 |
| HSBC | Sean McLoughlin | $215 | $178.24 | -74.9% | Aug 12, 2024 |
| Morgan Stanley | Andrew Percoco | $220 | $174.03 | -74.3% | Aug 1, 2024 |
| Mizuho Securities | Maheep Mandloi | $208 | $160 | -75.7% | Jul 26, 2024 |
| Daiwa | Dennis Ip | $201.5 | $177.18 | -76.4% | Jun 21, 2024 |
| Argus Research | John Eade | $190 | $177.52 | -77.8% | Jun 13, 2024 |
| RBC Capital | Christopher Dendrinos | $180 | $177.32 | -79.0% | May 30, 2024 |
| Morgan Stanley | Andrew Percoco | $167 | $163.85 | -80.5% | May 23, 2024 |
| Mizuho Securities | Maheep Mandloi | $164 | $151.91 | -80.8% | May 1, 2024 |
| Evercore ISI | James West | $174 | $134.75 | -79.7% | Apr 17, 2024 |
| Raymond James | Patel Molchanov | $160 | $130.07 | -81.3% | Apr 16, 2024 |
| Goldman Sachs | Joe Ritchie | $154 | $131.75 | -82.0% | Apr 16, 2024 |
| Mizuho Securities | Maheep Mandloi | $154 | $134 | -82.0% | Apr 15, 2024 |
| RBC Capital | Christopher Dendrinos | $160 | $140 | -81.3% | Apr 1, 2024 |
Track every rating change on GEV the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.